Pillstats
Rx only · Tablet, Orally Disintegrating · Oral

Hyoscyamine Sulfate

Brands: Levsin Sl · Hyoscyamine Sulfate

8 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US8 NDCs
8 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
RxCUI (US)153970
US makers8 labelers
Packages8
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 4 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.762$1.52$2.29$3.05Jan 2025Mar 2026Jul 2026
$0.806
Latest avg · Jul 22, 2026
-70%
Since Jan 7, 2025
8
Active US suppliers
25%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

2.0K4.1K6.1K8.1K2025 Q12025 Q22025 Q32025 Q42026 Q1
6.0K
Rx · 2026 Q1
379K
Units dispensed
-15%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it8 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
PD-Rx Pharmaceuticals, Inc.unknown1SUPPLYING
Acella Pharmaceuticals, LLCunknown1SUPPLYING
ANI Pharmaceuticals, Inc.unknown1SUPPLYING
Viatris Specialty LLCunknown1SUPPLYING
Chartwell RX, LLCunknown1SUPPLYING
Granulation Technology, Inc.unknown1SUPPLYING
Westminster Pharmaceuticals, LLCunknown1SUPPLYING
Patrin Pharma, Inc.unknown1SUPPLYING

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.